Position in AZN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$7,584
New position
Shares Held
40
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,388
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gleason Group, Inc. holds $4,846,851 across 10 Drug Manufacturers - General names. AZN ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
6,605 | $1,677,471 | |
| 2 | LLY |
ELI LILLY & Co
|
1,368 | $1,640,820 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
9,418 | $1,189,870 | |
| 4 | AMGN |
Amgen Inc
|
389 | $140,864 | |
| 5 | MRK |
Merck & Co., Inc.
|
899 | $115,521 | |
| 6 | ABBV |
AbbVie Inc.
|
220 | $55,360 | |
| 7 | NVS |
Novartis AG
|
62 | $9,716 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
40 | $7,584 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,584 | 40 | Shares | Sole | 2026-07-13 | |
| No filing history on record for this holder in this stock. | ||||||